Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study

NCT07007351 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Aging

Interventions

DEVICE: Intradermal injection

Sponsor

Laboratoires FILLMED